| Description |
1 online resource (358 p.) |
| Contents |
Front Cover -- Recent Advances and Future Perspectives of Microbial Metabolites -- Copyright Page -- Contents -- List of contributors -- About the editors -- 1. The therapeutic role of microbial metabolites in human health and diseases -- 1.1 Background -- 1.2 Mode of action of microbial metabolites -- 1.2.1 Diabetes mellitus -- 1.2.2 Cardiovascular disease -- 1.2.3 Neurological disorder -- 1.2.4 Gastrointestinal disorder -- 1.2.5 Colorectal cancer -- 1.3 Therapeutical effects of microbial metabolites in human health and diseases -- 1.3.1 Short-chain fatty acid -- 1.3.2 Bile acids |
|
1.3.3 Imidazole propionate -- 1.3.4 Trimethylamine N-oxide -- 1.3.5 4-Ethylphenylsulfate -- 1.3.6 N-Acyl amides -- 1.3.7 Branched-chain amino acids -- 1.3.8 Long-chain fatty acids -- 1.3.9 Indole derivative metabolites -- 1.3.10 Taurine -- 1.3.11 Desaminotyrosine -- 1.3.12 Retionic acid -- 1.3.13 Polyamines -- 1.4 Conclusion -- References -- 2. Peptides with therapeutic applications from microbial origin -- 2.1 Introduction -- 2.2 Substrates for peptide production -- 2.3 Methods in peptide production -- 2.4 Hydrolysis by enzyme -- 2.5 Microbial fermentation -- 2.6 Computational approach |
|
2.7 Hybrid approach -- 2.8 Pharmacological properties of microbial peptides -- 2.9 Pharmacological properties of bacterial peptides -- 2.10 Pharmacological properties of fungal peptides -- 2.11 Pharmacological properties of yeast peptides -- 2.12 Challenges -- 2.13 Conclusion and future perspectives of bioactive peptides -- References -- 3. Current status of microbial lectins in biomedical research -- 3.1 Introduction -- 3.2 Types of microbial lectins -- 3.3 Characterization of lectins -- 3.4 Application of lectins in biomedical research -- 3.4.1 Antibiofilm and antibacterial activity |
|
3.4.2 Biosensor -- 3.4.3 Cancer diagnosis and cancer therapy -- 3.4.4 Antinociceptive activity -- 3.4.5 Anti-inflammatory activity -- 3.4.6 Antiviral activity -- 3.4.7 Antioxidant activity -- 3.4.8 Lectibodies -- 3.4.9 Multifarious applications -- 3.5 Conclusion -- Reference -- 4. Current trends and future perspectives of probiotics on human health: an overview -- 4.1 Introduction -- 4.2 History and development of probiotics -- 4.3 Beneficial activities of probiotics -- 4.3.1 Problems related to the digestive tract -- 4.3.1.1 Diarrhea -- 4.3.1.2 Helicobacter pylori infection |
|
4.3.1.3 Inflammatory bowel diseases -- 4.3.1.4 Lactose malabsorption -- 4.3.1.5 Constipation -- 4.3.1.6 Colorectal cancer -- 4.3.1.7 Necrotizing enterocolitis -- 4.3.2 Obesity -- 4.3.3 Diabetes -- 4.3.4 Allergy -- 4.3.5 Urogenital healthcare -- 4.3.6 Central nervous system -- 4.3.7 Bone diseases -- 4.3.8 Dermal problems -- 4.4 Next-generation probiotics -- 4.4.1 Genetically modified organisms -- 4.5 Conclusion -- References -- 5. Bacteriocin and its biomedical application with special reference to Lactobacillus -- 5.1 Introduction -- 5.2 Types of bacteriocin produced by lactic acid bacteria |
| Notes |
Description based upon print version of record |
|
5.3 Mode of action of lactic acid bacteria-bacteriocins |
| Form |
Electronic book
|
| Author |
Xu, Xiaoxia
|
|
Jin, Fengliang
|
|
Panda, Amrita Kumari
|
|
Ibrahim, K. Syed
|
| ISBN |
9780323901147 |
|
032390114X |
|
